Volume | 196,160 |
|
|||||
News | - | ||||||
Day High | 283.4963 | Low High |
|||||
Day Low | 279.57 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Bio Rad Laboratories Inc | BIO | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
280.75 | 279.57 | 283.4963 | 279.83 | 279.31 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
7,715 | 196,160 | $ 281.52 | $ 55,222,288 | - | 261.59 - 473.50 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:00:00 | 24,718 | $ 279.83 | USD |
Bio Rad Laboratories (BIO) Options Flow Summary
Bio Rad Laboratories Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
7.98B | 28.52M | - | 2.67B | -637.32M | -22.35 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Bio Rad Laboratories News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BIO Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 275.27 | 283.4963 | 268.3325 | 274.62 | 253,191 | 4.56 | 1.66% |
1 Month | 322.38 | 339.90 | 268.3325 | 289.84 | 222,263 | -42.55 | -13.20% |
3 Months | 326.11 | 364.24 | 268.3325 | 319.67 | 215,470 | -46.28 | -14.19% |
6 Months | 288.87 | 364.24 | 268.3325 | 314.32 | 237,446 | -9.04 | -3.13% |
1 Year | 453.60 | 473.50 | 261.59 | 339.77 | 228,280 | -173.77 | -38.31% |
3 Years | 631.97 | 832.70 | 261.59 | 464.33 | 189,614 | -352.14 | -55.72% |
5 Years | 303.93 | 832.70 | 261.59 | 455.49 | 200,200 | -24.10 | -7.93% |
Bio Rad Laboratories Description
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier. |